Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 216

Similar articles for PubMed (Select 9682041)

1.

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG.

N Engl J Med. 1998 Jul 30;339(5):292-9.

2.

Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study.

Konno S, Suzuki S, Masuda M, Nagane Y, Tsuda E, Murai H, Imai T, Fujioka T, Suzuki N, Utsugisawa K.

PLoS One. 2015 May 12;10(5):e0126579. doi: 10.1371/journal.pone.0126579. eCollection 2015.

3.

Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.

Pasqualetti S, Congiu T, Banfi G, Mariotti M.

Int J Exp Pathol. 2015 Feb;96(1):11-20. doi: 10.1111/iep.12106. Epub 2015 Jan 21.

PMID:
25603732
4.
5.

Alendronate Effect on the Prevention of Bone loss in Early Stages of Ankylosing Spondylitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Khabbazi A, Noshad H, Gafarzadeh S, Hajialiloo M, Kolahi S.

Iran Red Crescent Med J. 2014 Jun;16(6):e18022. doi: 10.5812/ircmj.18022. Epub 2014 Jun 5.

6.

A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.

Hansen KE, Kleker B, Safdar N, Bartels CM.

Semin Arthritis Rheum. 2014 Aug;44(1):47-54. doi: 10.1016/j.semarthrit.2014.02.002. Epub 2014 Feb 11. Review.

PMID:
24680381
7.

Do atypical femoral fractures in patients with prolonged alendronate treatment heal?

Atik OS, Ozt├╝rk AM, Kunat C, Cetinkaya M, Kaptan Y.

Eklem Hastalik Cerrahisi. 2014;25(1):52-5. doi: 10.5606/ehc.2014.11.

8.

Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures.

de Villiers TJ.

Climacteric. 2014 Feb;17(1):101. No abstract available.

PMID:
24571030
9.
10.

The impact of alendronate on bone mineral density of osteoporotic patients.

Aghaei-Meybodi H, Rashidi N, Montazeri M, Keshtkar A, Khashayar P.

Acta Med Iran. 2013;51(12):855-60.

11.

[A Meta-analysis of alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis].

Yang L, Tian JH, He ZY, Tang XL, Yang KH.

Zhonghua Nei Ke Za Zhi. 2013 Oct;52(10):838-43. Chinese.

PMID:
24378061
12.

Synergistic antiosteoporotic effect of Lepidium sativum and alendronate in glucocorticoid-induced osteoporosis in Wistar rats.

Elshal MF, Almalki AL, Hussein HK, Khan JA.

Afr J Tradit Complement Altern Med. 2013 Aug 12;10(5):267-73. eCollection 2013.

13.

Natural history and risk factors for adjacent vertebral fractures in the fracture intervention trial.

Frankel B, Krishna V, Vandergrift A, Bauer DC, Nicholas J.

Spine (Phila Pa 1976). 2013 Dec 1;38(25):2201-7. doi: 10.1097/BRS.0000000000000025.

PMID:
24285276
14.

Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect.

Saag KG, Curtis J, Warriner A.

J Rheumatol. 2013 Oct;40(10):1640-2. doi: 10.3899/jrheum.130980. No abstract available.

PMID:
24085752
15.

Juvenile osteoporosis in a 5-year-old girl.

Sanghai SR, Shah I.

J Nat Sci Biol Med. 2013 Jul;4(2):476-7. doi: 10.4103/0976-9668.116979.

16.

[Secondary osteoporosis or secondary contributors to bone loss in fracture. Abnormal bone metabolism in pulmonary diseases].

Hirai T.

Clin Calcium. 2013 Sep;23(9):1321-6. doi: CliCa130913211326. Review. Japanese.

PMID:
23999369
17.

[The compliance in elderly male with osteoporosis treated with oral alendronate].

Jiang Y, Pi HY, Yan YF, Hou HR, Liu MY, Fang FS, Pei Y, Li CL.

Zhonghua Nei Ke Za Zhi. 2013 May;52(5):387-9. Chinese.

PMID:
23945303
18.

The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study.

Majumdar SR, Lix LM, Morin SN, Yogendran M, Metge CJ, Leslie WD.

J Rheumatol. 2013 Oct;40(10):1736-41. doi: 10.3899/jrheum.130041. Epub 2013 Jul 1.

PMID:
23818715
19.

[The effects of glucocorticoid on bone architecture and strength].

Soen S.

Clin Calcium. 2013 Jul;23(7):993-9. doi: CliCa1307993999. Review. Japanese.

PMID:
23811587
20.

Quercetin prevents experimental glucocorticoid-induced osteoporosis: a comparative study with alendronate.

Derakhshanian H, Djalali M, Djazayery A, Nourijelyani K, Ghadbeigi S, Pishva H, Saedisomeolia A, Bahremand A, Dehpour AR.

Can J Physiol Pharmacol. 2013 May;91(5):380-5. doi: 10.1139/cjpp-2012-0190. Epub 2013 Jan 22.

PMID:
23656499
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk